ENTREMED |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 08/07 | CASI Pharmaceuticals Names Daniel Lang CFO | MT |
| 08/07 | CASI Pharmaceuticals, Inc. Appoints Daniel Lang as CFO | CI |
Chart calendar ENTREMED
a2bab7cedae4424a21adb7d6.F07zihZpGPt7ao9W4f559UG-DETm3dbeX0X6HRWRghQ.fB_EwXgad4ITOL8wsqpAsXGNbwWWi7mvaT2jKCTn8Hd-D5DjXx1JnSkg6A~0b1d205ae215e13f11b1bf86c3650bff
Upcoming events on ENTREMED
Past events on ENTREMED
| 20/05/2024 | Q1 2024 Earnings Release |
| 28/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 14/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 11/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 17/05/2023 | Q1 2023 Earnings Release |
| 26/04/2023 | Q4 2022 Earnings Release |
| 14/11/2022 05:30 pm | Q3 2022 Earnings Release |
| 12/08/2022 05:30 pm | Interim 2022 Earnings Call |
| 12/08/2022 04:30 pm | Interim 2022 Earnings Release |
| 02/06/2022 | Reverse Split: 1 of 10 |
| 25/05/2022 06:30 pm | Annual General Meeting |
| 12/05/2022 05:30 pm | Q1 2022 Earnings Call |
| 12/05/2022 04:30 pm | Q1 2022 Earnings Release |
| 28/03/2022 05:30 pm | FY 2021 Earnings Call |
| 28/03/2022 04:30 pm | FY 2021 Earnings Release |
| 12/12/2021 04:00 am | American Society of Hematology Virtual Meeting and Exposition |
| 18/11/2021 | Jefferies London Healthcare Conference |
| 12/11/2021 06:30 pm | Q3 2021 Earnings Call |
| 12/11/2021 05:30 pm | Q3 2021 Earnings Release |
| 21/09/2021 09:35 pm | Oppenheimer Fall Healthcare Life Sciences & MedTech Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,13 7,82 -47.16% | 15,1 14,7 3.05% | 30,2 30,1 0.29% | 43,1 38,7 11.51% | 33,9 36,4 -6.97% | 19,8 |
|
EBITDA Million USD | Released Forecast Spread | -32,2 -32,1 -0.3% | -31,7 -32,4 1.91% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -40,0 -37,8 -5.75% | -33,7 -39,8 15.24% | -41,8 -37,6 -11.12% | -34,0 -27,6 -23.26% | -25,1 -25,1 -0% | -35,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -45,4 -40,4 -12.36% | -47,5 -39,9 -19.05% | -35,8 -37,9 5.44% | -37,4 -27,3 -37.08% | -26,3 -25,6 -2.52% | -35,8 |
|
Net income Million USD | Released Forecast Spread | -46,0 -40,9 -12.54% | -48,3 -41,7 -15.71% | -36,7 -42,2 13.09% | -41,0 -26,5 -55.02% | -27,0 -26,0 -3.54% | -35,8 |
|
EPS USD | Released Forecast Spread | -4,80 -4,14 -15.97% | -4,40 -3,79 -16.24% | -2,70 -3,03 10.99% | -3,01 -1,65 -82.42% | -2,02 -1,93 -4.66% | -2,56 |
| Announcement Date | 16/03/20 | 30/03/21 | 28/03/22 | 26/04/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,06 9,24 -1.96% | 8,57 7,87 8.91% | 10,2 9,91 3.05% | 15,3 10,8 41.18% | 8,35 9,10 -8.27% | 9,82 10,1 -2.68% | 8,84 10,4 -15.25% | 6,87 9,41 -26.97% | 3,41 12,0 -71.59% | 4,43 | 4,56 | 7,39 | 8,50 | 10,9 |
|
EBIT Million USD | Released Forecast Spread | -7,29 -13,1 44.24% | -7,75 -9,46 18.12% | -6,35 -7,61 16.54% | -12,6 -6,22 -103.21% | -9,35 -6,84 -36.7% | -5,10 -7,66 33.5% | -3,43 -3,26 -5.19% | -8,68 | -8,83 | -8,76 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,40 -12,0 29.88% | -7,49 -8,73 14.18% | -5,02 -6,88 27.03% | -16,5 -5,23 -216.02% | -10,1 -6,84 -47.09% | -4,45 -7,66 41.91% | -5,97 -3,26 -83.3% | -8,68 | -8,83 | -8,76 | ||||
|
Net income Million USD | Released Forecast Spread | -8,60 -12,1 28.75% | -7,68 -8,79 12.6% | -5,20 -6,93 24.92% | -19,5 -5,25 -272.42% | -10,2 -6,84 -49.78% | -4,64 -7,66 39.51% | -6,08 -3,26 -86.53% | -8,68 | -8,83 | -8,76 | ||||
|
EPS USD | Released Forecast Spread | -0,60 -0,87 30.77% | -0,56 -0,64 12.5% | -0,38 -0,46 17.99% | -1,44 -0,37 -289.19% | -0,45 -0,64 29.69% | -0,77 -0,50 -54% | -0,35 -0,56 37.5% | -0,46 -0,24 -91.67% | -0,71 -0,05 -1320% | -0,63 | -0,62 | -0,60 | -0,61 | -0,54 |
| Announcement Date | 12/05/22 | 12/08/22 | 14/11/22 | 26/04/23 | 17/05/23 | 11/08/23 | 14/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for ENTREMED
| Today 10:30 am | NOVARTIS AG: Q2 2024 Earnings Release |
| Today | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
| 17/07/2024 04:15 pm | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
| 17/07/2024 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
| 16/07/2024 | CAMURUS AB: Q2 2024 Earnings Release |
| 11/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 10/07/2024 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
| 09/07/2024 05:05 pm | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
| 04/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 02/07/2024 02:35 pm | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
- Stock Market
- Equities
- CASI Stock
- Stock
- Calendar ENTREMED
